“…In fact, 36.4% of patients with end-stage renal disease are reported to have clarithromycin-resistant strains, which is significantly higher than in non-uremic controls (15.2%) (69). As summarized in Table 4 (4,28,31,32,35,38,46,(70)(71)(72)(73)(74)(75), each eradication regimen previously reported use of different PPIs (omeprazole, lansopprazole, esomeprazole) and/or antibiotics (clarithromycin, amoxicillin and metronidazole), and variation of the duration of treatment from 7 days to more than 3 weeks. However, there is no significant difference in the overall cure rates among the different studies listed.…”